These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17111239)

  • 1. Use of gastroprotective agents in recommended doses in hospitalized patients receiving NSAIDs: a drug utilization study.
    Erdeljic V; Francetic I; Macolic Sarinic V; Bilusic M; Makar Ausperger K; Huic M; Mercep I
    Pharm World Sci; 2006 Oct; 28(5):318-25. PubMed ID: 17111239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study.
    Johnell K; Fastbom J
    Clin Drug Investig; 2008; 28(11):687-95. PubMed ID: 18840011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database.
    Schnitzer TJ; Kong SX; Mavros PP; Straus WL; Watson DJ
    Clin Ther; 2001 Dec; 23(12):1984-98. PubMed ID: 11813933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-prescription of gastroprotective agents and their efficacy in elderly patients taking nonsteroidal anti-inflammatory drugs: a systematic review of observational studies.
    Medlock S; Eslami S; Askari M; Taherzadeh Z; Opondo D; de Rooij SE; Abu-Hanna A
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1259-1269.e10. PubMed ID: 23792548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription audit of NSAIDs and gastroprotective strategy in elderly in primary care.
    Al Khaja KAJ; Veeramuthu S; Isa HA; Sequeira RP
    Int J Risk Saf Med; 2017; 29(1-2):57-68. PubMed ID: 28885223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of prophylactic gastroprotective therapy in patients with nonsteroidal anti-inflammatory drug- and aspirin-associated ulcer bleeding: a cross-sectional study.
    Ho CW; Tse YK; Wu B; Mulder CJ; Chan FK
    Aliment Pharmacol Ther; 2013 Apr; 37(8):819-24. PubMed ID: 23432193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population.
    Rahme E; Pettitt D; LeLorier J
    Arthritis Rheum; 2002 Nov; 46(11):3046-54. PubMed ID: 12428249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of interventions by community pharmacists to reduce risk of gastrointestinal side effects in nonselective nonsteroidal anti-inflammatory drug users.
    Teichert M; Griens F; Buijs E; Wensing M; De Smet PA
    Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):382-9. PubMed ID: 24535837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal antiinflammatory drug use among patients with GI bleeding.
    Dominick KL; Bosworth HB; Jeffreys AS; Grambow SC; Oddone EZ; Horner RD
    Ann Pharmacother; 2004; 38(7-8):1159-64. PubMed ID: 15187205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rate of prescribing gastrointestinal prophylaxis with either a proton pump inhibitor or an H2-receptor antagonist in Nova Scotia seniors starting nonsteroidal anti-inflammatory drug therapy.
    Superceanu B; Veldhuyzen van Zanten S; Skedgel C; Shepherd M; Sketris I
    Can J Gastroenterol; 2010 Aug; 24(8):481-8. PubMed ID: 20711527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies.
    Pilotto A; Franceschi M; Leandro G; Di Mario F;
    Drugs Aging; 2003; 20(9):701-10. PubMed ID: 12831293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study.
    Valkhoff VE; van Soest EM; Masclee GM; de Bie S; Mazzaglia G; Molokhia M; Kuipers EJ; Sturkenboom MC
    Aliment Pharmacol Ther; 2012 Oct; 36(8):790-9. PubMed ID: 22928490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
    Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
    J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes.
    van Leen MW; van der Eijk I; Schols JM
    Age Ageing; 2007 Jul; 36(4):414-8. PubMed ID: 17537740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.
    Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G
    Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
    Scheiman JM; Hindley CE
    Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.
    Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N
    CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The COX-2 inhibitor market withdrawals and prescribing patterns by rheumatologists in patients with gastrointestinal and cardiovascular risk.
    Greenberg JD; Fisher MC; Kremer J; Chang H; Rosenstein ED; Kishimoto M; Lee S; Yazici Y; Kavanaugh A; Abramson SB;
    Clin Exp Rheumatol; 2009; 27(3):395-401. PubMed ID: 19604430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.